Page last updated: 2024-10-28

hydrochlorothiazide and Cruveilhier-Baumgarten Syndrome

hydrochlorothiazide has been researched along with Cruveilhier-Baumgarten Syndrome in 1 studies

Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.

Cruveilhier-Baumgarten Syndrome: Liver cirrhosis with intrahepatic portal obstruction, HYPERTENSION, and patent UMBILICAL VEINS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mansurov, KhKh1
Nikolaeva, OS1

Other Studies

1 other study available for hydrochlorothiazide and Cruveilhier-Baumgarten Syndrome

ArticleYear
[Reduction of portal stasis in liver cirrhosis by some medicinal preparations].
    Klinicheskaia meditsina, 1971, Volume: 49, Issue:2

    Topics: Aminophylline; Humans; Hydrochlorothiazide; Hypertension, Portal; Liver Cirrhosis; Pituitary Hormone

1971